Cargando…

Ultrasound‐guided percutaneous metal‐organic frameworks based codelivery system of doxorubicin/acetazolamide for hepatocellular carcinoma therapy

Detalles Bibliográficos
Autores principales:	Jing, Ziwei, Wang, Xiaohui, Li, Na, Sun, Zhi, Zhang, Dingding, Zhou, Lin, Yin, Fanxiang, Jia, Qingquan, Wang, Mengli, Chu, Yaojuan, Du, Shuzhang, He, Yaping, Du, Qiuzheng, Zhang, Xiaojian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516336/ https://www.ncbi.nlm.nih.gov/pubmed/34709761 http://dx.doi.org/10.1002/ctm2.600

Ejemplares similares

Association of Coronary Artery Disease and Metabolic Syndrome: Usefulness of Serum Metabolomics Approach
por: Jing, Ziwei, et al.
Publicado: (2021)

Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
por: Zhang, Yi, et al.
Publicado: (2018)

Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
por: Zhang, Yi, et al.
Publicado: (2018)

Enhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicin
por: Zou, Seyin, et al.
Publicado: (2012)

Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
por: Jin, Xun, et al.
Publicado: (2016)

Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer
por: Li, Ke, et al.
Publicado: (2019)

Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin
por: Han, Yiqun, et al.
Publicado: (2014)

Functionalized Large-Pore Mesoporous Silica Microparticles for Gefitinib and Doxorubicin Codelivery
por: Li, Yan, et al.
Publicado: (2019)

Codelivery of Doxorubicin and Paclitaxel by Cross-Linked Multilamellar Liposome Enables Synergistic Antitumor Activity
por: Liu, Yarong, et al.
Publicado: (2014)

Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma
por: Zhang, Yue, et al.
Publicado: (2017)

Dual Targeted Nanoparticles for the Codelivery of Doxorubicin and siRNA Cocktails to Overcome Ovarian Cancer Stem Cells
por: Chen, Li, et al.
Publicado: (2023)

A Modular Coassembly Approach to All-In-One Multifunctional Nanoplatform for Synergistic Codelivery of Doxorubicin and Curcumin
por: Yang, Muyang, et al.
Publicado: (2018)

Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer
por: Zhao, Xiaojing, et al.
Publicado: (2014)

Smart Magnetic Nanocarriers for Codelivery of Nitric Oxide and Doxorubicin for Enhanced Apoptosis in Cancer Cells
por: Dutta, Bijaideep, et al.
Publicado: (2023)

Dual-Functional Peptide Driven Liposome Codelivery System for Efficient Treatment of Doxorubicin-Resistant Breast Cancer
por: Ahmed, Kamel S, et al.
Publicado: (2021)

Cascade targeting codelivery of ingenol-3-angelate and doxorubicin for enhancing cancer chemoimmunotherapy through synergistic effects in prostate cancer
por: Wang, Zhicheng, et al.
Publicado: (2021)

UHPLC-HRMS-based metabolomic and lipidomic characterization of glioma cells in response to anlotinib
por: Shi, Yingying, et al.
Publicado: (2023)

Codelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancer
por: Wang, Bi-Lan, et al.
Publicado: (2013)

Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment
por: Wang, Dandan, et al.
Publicado: (2017)

Codelivery of doxorubicin and triptolide with reduction-sensitive lipid–polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment
por: Wu, Bo, et al.
Publicado: (2017)

Self-Assembling pH-Responsive Nanoparticle Platform Based on Pectin–Doxorubicin Conjugates for Codelivery of Anticancer Drugs
por: Tao, Yinghua, et al.
Publicado: (2021)

Enzyme-Enhanced Codelivery of Doxorubicin and Bcl-2 Inhibitor by Electrospun Nanofibers for Synergistic Inhibition of Prostate Cancer Recurrence
por: Liu, Zheng, et al.
Publicado: (2022)

Aptamer-Mediated Codelivery of Doxorubicin and NF-κB Decoy Enhances Chemosensitivity of Pancreatic Tumor Cells
por: Porciani, David, et al.
Publicado: (2015)

Surface PEGylated Cancer Cell Membrane-Coated Nanoparticles for Codelivery of Curcumin and Doxorubicin for the Treatment of Multidrug Resistant Esophageal Carcinoma
por: Gao, Yi, et al.
Publicado: (2021)

A nanoselenium-coating biomimetic cytomembrane nanoplatform for mitochondrial targeted chemotherapy- and chemodynamic therapy through manganese and doxorubicin codelivery
por: Xiao, Jianmin, et al.
Publicado: (2021)

Factors associated with burnout and job satisfaction in Chinese hospital pharmacists
por: Zhao, Jie, et al.
Publicado: (2020)

Biodegradable Alginate-Chitosan Hollow Nanospheres for Codelivery of Doxorubicin and Paclitaxel for the Effect of Human Lung Cancer A549 Cells
por: Tao, Liu, et al.
Publicado: (2018)

Multistage pH-responsive codelivery liposomal platform for synergistic cancer therapy
por: Zhao, Ting, et al.
Publicado: (2022)

Codelivery of Doxorubicin and MDR1-siRNA by Mesoporous Silica Nanoparticles-Polymerpolyethylenimine to Improve Oral Squamous Carcinoma Treatment [Corrigendum]
Publicado: (2021)

Response to “Acetazolamide and Cardiac Failure”
por: Imiela, Tomasz, et al.
Publicado: (2018)

Acetazolamide: Treatment of Psychogenic Polydipsia
por: Ahmed, Syed E, et al.
Publicado: (2017)

Stroke Mimic Caused by Acetazolamide
por: Mendes, Tiago Manuel
Publicado: (2018)

Drug-drug cocrystals: Opportunities and challenges
por: Wang, Xiaojuan, et al.
Publicado: (2021)

Nucleus-selective codelivery of proteins and drugs for synergistic antitumor therapy
por: Yang, Lan, et al.
Publicado: (2022)

Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers
por: Kumar, Girish, et al.
Publicado: (2023)

Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance
por: Haghiralsadat, Fateme, et al.
Publicado: (2018)

Acetazolamide-based fungal chitinase inhibitors
por: Schüttelkopf, Alexander W., et al.
Publicado: (2010)

Acetazolamide: Old drug, new evidence?
por: Shukralla, Arif Ali, et al.
Publicado: (2022)

Visual Recognition and Detection of Clindamycin by Au@Ag Core–Shell Nanoparticles
por: Du, Qiuzheng, et al.
Publicado: (2021)

Codelivery of zoledronic acid and doublestranded RNA from core-shell nanoparticles
por: Chen, Li, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tuqdeqm1i815qi6j3c42bedarq